about
Design, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydrationDevelopment of probiotic tablets using microparticles: viability studies and stability studies.In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations.Nanotechnological carriers for cancer chemotherapy: the state of the art.Delivery Systems for Biopharmaceuticals. Part I: Nanoparticles and Microparticles.Delivery systems for biopharmaceuticals. Part II: Liposomes, Micelles, Microemulsions and Dendrimers.Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.Characterization and biocompatibility evaluation of cutaneous formulations containing lipid nanoparticles.Scaffolds for Bone Regeneration: State of the Art.Permeation of topically applied caffeine from a food by-product in cosmetic formulations: Is nanoscale in vitro approach an option?New Thermoresponsive Eyedrop Formulation Containing Ibuprofen Loaded-Nanostructured Lipid Carriers (NLC): Development, Characterization and Biocompatibility Studies.Exploring the antioxidant potentiality of two food by-products into a topical cream: stability, in vitro and in vivo evaluation.Coffee silverskin: a possible valuable cosmetic ingredient.Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems.Vaginal suppositories containing Lactobacillus acidophilus: development and characterization.Assessing a novel polymer-wick based electrode for EEG neurophysiological research.Women's experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal.Influence of drug incorporation, temperature and storage time on the pH, textural and rheological properties of different poloxamer hydrogels.In vivo skin irritation potential of a Castanea sativa (Chestnut) leaf extract, a putative natural antioxidant for topical application.Photodegradation of avobenzone: stabilization effect of antioxidants.Comparison of different chemometric and analytical methods for the prediction of particle size distribution in pharmaceutical powders.Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters.Intranasal lipid nanoparticles for the treatment of neurodegenerative diseases.Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review.In-service characterization of a polymer wick-based quasi-dry electrode for rapid pasteless electroencephalography.Development of an injectable PHBV microparticles-GG hydrogel hybrid system for regenerative medicine.Study of the isoflavone content of different extracts of Medicago spp. as potential active ingredientMedicago spp. extracts as promising ingredients for skin care productsEffects of encapsulation on the viability of probiotic strains exposed to lethal conditionsRheological Properties of Vaginal Hydrophilic Polymer GelsCharacterization, sensorial evaluation and moisturizing efficacy of nanolipidgel formulationsIn vitroandin vivocomparative study of cosmetic ingredients Coffee silverskin and hyaluronic acidSolid lipid nanoparticles (SLN) - based hydrogels as potential carriers for oral transmucosal delivery of Risperidone: Preparation and characterization studiesEDITORIAL: Advances in Pharmaceutical BiotechnologyEditorial: New Trends in Pharmaceutical NanotechnologyCharacterization of an antioxidant surfactant-free topical formulation containing Castanea sativa leaf extractComparison between sensory and instrumental characterization of topical formulations: impact of thickening agentsNose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisisFunctionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies
P50
Q28392702-F9E4E3FB-1071-4A29-9B5E-89E9F39CA0ACQ36636470-636E82BF-554C-4EE0-A4CE-B796061BA57FQ38152173-2CEA4E9E-53DB-4BCE-8F35-3026F04A6432Q38319607-2AFD1FC5-2C8B-472B-881B-40076EA92248Q38560033-F2F564D4-6BC2-4023-8D82-5BE282F9553DQ38567718-55397796-7B95-4781-8225-7A18124B8F13Q38594185-7B8A0717-9B04-46C1-A149-B0DB98277EB9Q38714705-CA526945-9023-46B4-8AA4-EB5977FE0621Q38718951-81F9CF20-1022-4B3A-83E3-49A5A6011F4CQ38722991-58F83F12-3734-490F-9AE4-816D44923A30Q38738457-FD2D4259-54A2-4D29-A8C7-EF8D977C8C41Q38824851-0EC40119-00EB-44C5-B975-940384F161B5Q38833527-3B6E97BE-181F-4917-9529-22D6E812BE71Q38932552-98D469B8-A3C3-463B-8339-3A6E3AFB8D51Q38935547-83C398A2-3B30-4848-B10D-29F30EDB49C9Q38952328-D88BAA88-0DCC-4455-9E7F-20DB21CA85CDQ39841387-189EDE6B-0209-4A61-AEFD-4F35329BDBC6Q41588595-298DFEA7-15E4-43C1-823F-E39B46C3E2A2Q44583926-E5067EBD-2185-4495-94D9-0853AD37C138Q46366652-DE108CE6-CB13-436D-A739-012AB9695A59Q46857288-8FE136C0-CF0F-49C5-8C30-06BCA9D44313Q47411122-A15E0F4E-1FF0-4B2F-BB10-983404B58746Q47936564-005BA5DE-98A4-4688-AF13-1E7814A31B38Q47943181-D4C885EF-50F3-49FA-8D86-7461B474DBE1Q49567719-9321817E-1065-4008-B1C6-7D914D2F1F61Q50891130-0F2E8316-B0FD-4EEA-8803-1DF6EC976A71Q53378432-9A37A55F-0666-47FA-A25F-212C2E95823CQ57570817-2001C574-F906-4759-9526-8AEB3B054E91Q57570834-ACBEBC08-B63F-4D6B-8535-194817BDBC40Q57757895-6DF6AD02-BA68-4A01-98D3-8F390A6A0A9AQ58464860-7A98CB0C-7771-46C1-8122-31E41C3D8CB7Q59342766-86846547-7D67-4BB3-950B-AE4C8A52E0F7Q59385242-048BDC11-736F-43AB-8132-08CFA447479CQ61818368-F94738C8-48B1-4BF5-AA4D-71287EE26251Q86010556-0979BBC3-1666-4BBF-9A1B-B7966090DA81Q86302804-AA24DC36-2045-4A26-A8FA-175465FFB892Q86642063-BEEE00E6-67C2-4214-AFE7-94A230A8BFCBQ86966415-327C3793-DAD1-477A-813D-ED907D69FCCBQ90899731-088D1C2E-1A62-4853-B147-54F0AB31D472Q92917505-D18DAF38-F13E-4D0B-B293-EAB50ED3D098
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Helena Amaral
@ast
Maria Helena Amaral
@en
Maria Helena Amaral
@es
Maria Helena Amaral
@nl
type
label
Maria Helena Amaral
@ast
Maria Helena Amaral
@en
Maria Helena Amaral
@es
Maria Helena Amaral
@nl
prefLabel
Maria Helena Amaral
@ast
Maria Helena Amaral
@en
Maria Helena Amaral
@es
Maria Helena Amaral
@nl
P106
P1153
7006683770
P21
P31
P496
0000-0002-3209-3366